FDA Inspection
Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant)Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant) – FDA Inspection, Mar 14, 2025
Record Details
This FDA Inspection record concerns Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant), with an inspection on March 14, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
- Inspection Date
- March 14, 2025
- Product Type
- Human Drugs
View Company Profile
ID · c4db414c-686b-4498-a4b8-2022ce9c30ef
Inspection Facts
- Inspection number
- 1261674
- FDA center
- Human Drugs
Other FDA inspections of Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant)
4| Date | Classification | Office | Project area |
|---|---|---|---|
| March 22, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 22, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 20, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 23, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant)
- FDA Inspection 1084107 - 2019-03-22
- FDA Inspection 981968 - 2016-07-22
- FDA Inspection 866095 - 2013-12-20
- FDA Inspection 582495 - 2009-04-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.